Urgent

Neonatal alloimmune thrombocytopenia (NAIT)

Platelet FMAIT, ICH risk · Paediatric
Physician-written · Verified by three sets of doctors · Reviewed November 2026

Bedside summary

NAIT results from maternal alloantibodies (most often anti-HPA-1a) crossing the placenta and destroying fetal/neonatal platelets, in a mother with a normal platelet count. It is the platelet equivalent of rhesus disease, can occur in a first pregnancy, and carries a significant risk of intracranial haemorrhage, so severe thrombocytopenia is treated urgently.

Red flags

  • Any intracranial haemorrhage on imaging or seizures/bulging fontanelle
  • Platelets <30 x10^9/L or active bleeding
  • Petechiae, purpura or mucosal bleeding
  • Rapidly falling count
  • Preterm infant with severe thrombocytopenia

Assessment

Differential diagnosis

  • Maternal autoimmune thrombocytopenia (ITP) passing antibody
  • Congenital/early-onset sepsis (including TORCH)
  • Disseminated intravascular coagulation
  • Congenital thrombocytopenia syndromes (TAR, Wiskott-Aldrich, Fanconi)
  • Birth asphyxia/placental insufficiency
  • Inherited/metabolic causes

Investigations

  • FBC with platelet count (often <50, may be <20) and blood film
  • Cranial ultrasound to exclude intracranial haemorrhage
  • Maternal and paternal HPA genotyping and maternal anti-HPA antibody screen
  • Coagulation screen and sepsis screen (exclude mimics)
  • Repeat platelet counts to track nadir (typically days 2-5)
  • Confirm maternal platelet count is normal (distinguishes from ITP)

Management

  • Recognise severe isolated thrombocytopenia in an otherwise well term baby as possible NAIT
  • Perform urgent cranial ultrasound to look for intracranial haemorrhage
  • Send maternal/neonatal samples for HPA typing and antibody confirmation but do not delay treatment for results
  • Transfuse platelets urgently for very low counts or any bleeding — HPA-compatible (e.g. HPA-1a/5b-negative) platelets are ideal
  • If compatible platelets are unavailable, give random-donor platelets without delay — they still raise the count
  • Give IVIG for ongoing/refractory thrombocytopenia
  • Set transfusion thresholds higher than usual given ICH risk (see drugs)
  • Avoid intramuscular injections and traumatic procedures until count is safe
  • Monitor platelet counts closely until recovery
  • Counsel parents and arrange fetal medicine planning for future pregnancies (antenatal IVIG)

Drugs & doses

HPA-compatible (or random-donor if unavailable) platelets 10-20 mL/kg IV for severe thrombocytopenia/bleeding
IV immunoglobulin 1 g/kg/day for 1-2 days (or 0.4-0.8 g/kg/day regimens) for refractory cases
Transfusion thresholds: platelets <30 x10^9/L if asymptomatic, <50 if unwell/preterm, maintain >100 if intracranial haemorrhage
Avoid IM vitamin K formulation if feasible pre-treatment (use alternative route per local policy)

Disposition

Admit to neonatal unit; urgent platelet transfusion/IVIG and cranial imaging. Haematology and fetal-medicine referral for the family's future pregnancies.

Complications & pitfalls

  • Intracranial haemorrhage (antenatal or postnatal) with neurodisability
  • Other major haemorrhage
  • Recurrence in subsequent pregnancies, often more severe
  • Transfusion-related complications
  • Death from ICH

Exam pearls

  • NAIT occurs in a mother with a NORMAL platelet count — this distinguishes it from maternal ITP
  • Do not withhold random-donor platelets waiting for HPA-matched units if the baby is bleeding or profoundly low
  • Can affect a first pregnancy and recurs (more severely) in later ones — refer to fetal medicine
  • Target a higher platelet count than usual because of the disproportionate ICH risk

Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.